Entero Therapeutics Stock Forward View - Price Action Indicator
| ENTODelisted Stock | 2.85 0.15 5.00% |
Entero Stock outlook is based on your current time horizon.
As of today the value of rsi of Entero Therapeutics' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Entero Therapeutics hype-based prediction, you can estimate the value of Entero Therapeutics from the perspective of Entero Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Entero Therapeutics after-hype prediction price | USD 2.85 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Entero |
Entero Therapeutics Additional Predictive Modules
Most predictive techniques to examine Entero price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Entero using various technical indicators. When you analyze Entero charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.21) | (0.21) |
| Check Entero Therapeutics Volatility | Backtest Entero Therapeutics | Information Ratio |
Entero Therapeutics Trading Date Momentum
| On February 15 2026 Entero Therapeutics was traded for 2.85 at the closing time. The top price for the day was 3.16 and the lowest listed price was 2.82 . There was no trading activity during the period 0.0. Lack of trading volume on February 15, 2026 did not affect price variability. The overall trading delta against the current closing price is 5.26% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare Entero Therapeutics to competition
Entero Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Entero Therapeutics stock to make a market-neutral strategy. Peer analysis of Entero Therapeutics could also be used in its relative valuation, which is a method of valuing Entero Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Entero Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Entero Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Entero Therapeutics shares will generate the highest return on investment. By undertsting and applying Entero Therapeutics stock market strength indicators, traders can identify Entero Therapeutics entry and exit signals to maximize returns.
Entero Therapeutics Risk Indicators
The analysis of Entero Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Entero Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting entero stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 7.46 | |||
| Standard Deviation | 9.64 | |||
| Variance | 93.02 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Entero Therapeutics
The number of cover stories for Entero Therapeutics depends on current market conditions and Entero Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Entero Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Entero Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Entero Therapeutics Short Properties
Entero Therapeutics' future price predictability will typically decrease when Entero Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Entero Therapeutics often depends not only on the future outlook of the potential Entero Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Entero Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.4 M | |
| Cash And Short Term Investments | 163.5 K |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Entero Stock
If you are still planning to invest in Entero Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Entero Therapeutics' history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |